Buy Like Buffett
Watchlist

Tandem Diabetes Care, Inc.

TNDM · Healthcare · $1.2B mkt cap · FY2025 filings · · not refreshed in 35 days · No moat ·

Doesn't clear the bar

No moat
Share / Embed this score
Embed this score

The five investor questions

49

2021–2025 (latest 5 aligned FYs; v3 window cap 5): revenue $703M to $1.0B, increasing; diluted EPS 0.24 to -3.04, decreasing.

72

Median gross margin 51.8% over 10y, stable.

0

Median ROIC -30.8%, above the 12% hurdle in 0% of years.

28

Net debt/EBITDA n/ax, interest coverage -24x.

44

Owner earnings changed trend unclear over up to the ten most recent annual observations, share count n/a.

Price vs. value if growth stopped today

A cautious baseline, not a price target: what the shares may support if normalized owner earnings simply hold steady.

Above value if growth stopped todayBelow value if growth stopped today
No price data
Not reported
Unavailable — insufficient owner-earnings data
Unavailable — insufficient growth-model data
$17.12
No price data

This zero-growth estimate assumes trailing owner earnings persist — unreliable for declining businesses. The recent FY revenue series does not trigger the three-consecutive-declines flag.

Among the current top-score group, the median current price is 239% above the zero-growth estimate across 48 of the current top 50 companies by Moat Score with both values.

Score records captured Jul 26, 2026.

Exactly which 50 companies?

FTNT, META, MEDP, IBEX, MSFT, GOOGL, LULU, ANF, IDXX, TXRH, FHI, QLYS, FFIV, ADBE, LLY, MANH, VEEV, GRMN, SSD, MNST, DOCS, MCO, CPRT, NTAP, LRCX, NVDA, CORT, SFM, MPTI, ULTA, SN, RMD, ROL, PAYC, IRMD, INTU, DECK, MORN, LGCY, DAL, GWW, ISRG, MPWR, CTAS, LOPE, MRK, CMG, FAST, BKNG, ORLY

Missing a usable price or zero-growth estimate: ANF, BKNG.

Model details under moat-index@3.0.0: zero-growth multiple 11.1×, capped-growth comparison at no more than 18×; 9% discount rate; high-end growth 0% (capped at 4%) using min(5y revenue CAGR, 5y diluted-EPS CAGR), clamped to 0%–4%; maintenance capex uses min(capex, D&A); abstain when D&A is unavailable. This is a disclosed model range, not intrinsic value as fact.

15 years of fundamentals

The business, in plain English

Tandem Diabetes Care, Inc. booked $1.0B of revenue in FY2025 in the Healthcare sector and kept 53.8% of it as gross profit — a solid-margin business by that measure. After every other cost, −20.2% of each revenue dollar reached the bottom line.

Across the filed record, revenue grew from $2.5M (FY2012) to $1.0B (FY2025) — about 58.8% a year compounded over 13 years.

It earned −39.5% on invested capital in the latest filed year, FY2025. Across the full 12-year measurable filed record, median ROIC was −36.8%. Over the v3 recent window (10 measurable filed years), median ROIC was −30.8%. The Returns on Capital filter above scores it 0/100.

The balance sheet carried $310M of total debt in FY2025. Balance-Sheet Safety scores it 28/100.

Put together: Pricing Power is the strongest of the five filters (72/100) and Returns on Capital the weakest (0/100), which is how TNDM lands at 39/100 — a None moat.

This breakdown is generated from the filed numbers and sub-scores above — no outside narrative, no estimates. Where a filing doesn’t disclose an input, the sentence that would need it is omitted instead of guessed.

FY2011–FY2025 · 15 fiscal years, normalized from TNDM’s SEC filings

Sales, as filed$1.0B FY2025
$0$500M$1B2011201620212025
Revenue kept after cost of goods53.8% FY2025
−50%0%50%2011201620212025
Standard ROIC or separately labeled Operating ROICROIC −39.5% FY2025
−200%−100%0%2011201620212025
Cash an owner could take out−$205M FY2025
−$200M−$100M$02011201620212025

Gaps in a line mean that item isn’t in TNDM’s filings for that year. The series is never interpolated or estimated. The Table view lists every filed value, including operating and net margins, total debt, and share count.

Flagship explainer

How Tandem Diabetes Care, Inc. makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$1.0B · 100%Cost of revenue$469M · 46%Gross profit$546M · 54%Operating income−$187M · −18%Income before tax−$200M · −20%Income tax$4.4M · 0%Net income−$205M · −20%As of 2025-12-31 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$1.0B100%
Cost of revenue$469M46%
$546M54%
−$187M−18%
Income before tax−$200M−20%
Income tax$4.4M0%
−$205M−20%
Source: · event Dec 31, 2025 · retrieved Jul 26, 2026 · annual-row source set
Embed this chart

Flagship explainer

What Tandem Diabetes Care, Inc. owns — and owes

Tandem Diabetes Care, Inc.'s filing tags don't support a full breakdown — here's what is filed:

Table alternative
Filed lineValue% of assetsSource
Total assets$881M100%
Cash and equivalents$90.6M10%
$310M35%
Stockholders’ equity$155M18%
Source: · event Dec 31, 2025 · retrieved Jul 26, 2026 · annual-row source set

Flagship explainer

What drives Tandem Diabetes Care, Inc.’s return on equity?

ROE is five filed business factors multiplied together.

DuPont return on equity factor treeReturn on equity branches into tax burden, interest burden, operating margin, asset turnover, and the equity multiplier.Return on equity−98%Tax burden102%net income ÷ pretax incomeInterest burden107%pretax ÷ operating incomeOperating margin−18%operating income ÷ revenueAsset turnover1.10×revenue ÷ average assetsEquity multiplier4.42×average assets ÷ average equityAs of 2025-12-31 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com
DuPont source inputs
InputValueFiscal yearSource
−$205MFY2025
Income before tax−$200MFY2025
Operating income−$187MFY2025
$1.0BFY2025
Ending assets$881MFY2025
Beginning assets$968MFY2024
$155MFY2025
$263MFY2024
Source:
  • SEC filingFiling detailsAccession 0001438133-26-000010
· event Dec 31, 2025 · retrieved Jul 26, 2026 · annual-row source set
Embed this chart

Flagship explainer

Where Tandem Diabetes Care, Inc.'s cash went

Tandem Diabetes Care, Inc.’s filing does not supply enough provenance-matched cash-flow lines for a truthful flow chart — here’s what is filed:

Table alternative
Filed lineValue% of cash from operationsSource
Cash from operations−$9.7M−100%
Depreciation and amortization$17.7M182%
Source: · event Dec 31, 2025 · retrieved Jul 26, 2026 · annual-row source set

Curated 19-manager tier

Who reported holding Tandem Diabetes Care, Inc.

Delayed public 13F reports for 2026-Q2—not live positions, trades, or recommendations.

0 holding0 exited0 not holding0/19 resolved19 not retrieved

Named manager positions and quarter-over-quarter changes
ManagerReported positionQuarter-over-quarterFiling accession
Abrams CapitalNot retrievedComparison not retrievedFiling not retrieved
Akre CapitalNot retrievedComparison not retrievedFiling not retrieved
Baupost GroupNot retrievedComparison not retrievedFiling not retrieved
Berkshire HathawayNot retrievedComparison not retrievedFiling not retrieved
Brave Warrior AdvisorsNot retrievedComparison not retrievedFiling not retrieved
Dodge & CoxNot retrievedComparison not retrievedFiling not retrieved
First EagleNot retrievedComparison not retrievedFiling not retrieved
FundsmithNot retrievedComparison not retrievedFiling not retrieved
Gardner Russo & QuinnNot retrievedComparison not retrievedFiling not retrieved
Gates Foundation TrustNot retrievedComparison not retrievedFiling not retrieved
Mairs & PowerNot retrievedComparison not retrievedFiling not retrieved
Markel / Markel-GaynerNot retrievedComparison not retrievedFiling not retrieved
Oakmark / Harris AssociatesNot retrievedComparison not retrievedFiling not retrieved
Pershing SquareNot retrievedComparison not retrievedFiling not retrieved
Polen CapitalNot retrievedComparison not retrievedFiling not retrieved
Sequoia / Ruane CunniffNot retrievedComparison not retrievedFiling not retrieved
Southeastern Asset ManagementNot retrievedComparison not retrievedFiling not retrieved
Tweedy, BrowneNot retrievedComparison not retrievedFiling not retrieved
Yacktman Asset ManagementNot retrievedComparison not retrievedFiling not retrieved

Position size uses shares and filed value from each manager’s 13F. Portfolio weight uses the eligible long-share filing denominator. Changes compare only with the immediately preceding calendar quarter.

Source: Filing source not retrieved · event Jun 30, 2026 · retrieved Jul 26, 2026

Flagship explainer

What Tandem Diabetes Care, Inc. insiders reported

Records still being gathered — partial as of retrieval Aug 30, 2026.

Partial coverage: the incomplete Form 4 walk cannot establish no activity, an activity date, or zero counts.

Moat Score history

16 logged readings since Jul 17, 2026 · append-only, never rewritten

Moat Score over timeLast scored reading of each day, on the 0–100 scale38.5 / 100
0406080100WideNarrowShallowNo moatJul 17, 2026Jul 26, 2026

Breaks in the line mark methodology or normalizer upgrades — readings across versions aren’t compared, so a level shift there isn’t a change in the business.

Tier changesSame-methodology and same-normalizer crossings of the Wide / Narrow / Shallow bars

  1. Normalizer upgraded unstamped (version unknown)moat-xbrl-normalizer@1.1.0 — readings across versions aren’t comparedJul 26, 2026
  2. Methodology upgraded moat-index@2.0.0moat-index@3.0.0 — readings across versions aren’t comparedJul 23, 2026
  3. Methodology upgraded moat-index@1.2.0moat-index@2.0.0 — readings across versions aren’t comparedJul 20, 2026

Scores are logged append-only and never overwritten — this record cannot be reconstructed retroactively, which is exactly why it’s worth keeping.

Insider activity

Form 4 reports mix P/S market or private transactions with compensation-plan mechanics. Activity casually described as “insider selling” can include compensation mechanics; awards, tax withholding, and option exercises are shown by their exact filed class here, never collapsed into “Bought” or “Sold.”

These are disclosed filing facts and arithmetic aggregates, not a signal or verdict.

This machine-readable surface covers SEC ownership filings from 2003; it does not represent earlier paper-era records.

Records still being gathered — partial as of retrieval Aug 30, 2026.

Among the rows shown, A/F/M acquisition, payment or withholding, and exercise or conversion rows outnumber S sale rows (39 versus 0). The filing codes alone do not establish that every such row arose from a compensation plan.

Trailing-12-month totals and the 90-day cluster result are withheld because this issuer walk is incomplete.

InsiderShares owned afterDateFiling detail
Vosseller LeighEVP & CHIEF FINANCIAL OFFICERExercise or conversion of derivative security (M)Table I · Acquired · Common Stock · 2 paired events4,120—Exercise or conversion of derivative security (M)—See lot detailAug 15, 2026
2 filed lots
  • Table I · Common Stock: 1,496 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 50,895 · Paired event: 1,496 Restricted Stock Unit → 1,496 Common Stock ·
  • Table I · Common Stock: 2,624 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 52,982 · Paired event: 2,624 Restricted Stock Unit → 2,624 Common Stock ·
Vosseller LeighEVP & CHIEF FINANCIAL OFFICERPayment of exercise price or tax liability (F)Table I · Disposed · Common Stock1,479$22.72$33,603See lot detailAug 15, 2026
2 filed lots
  • Table I · Common Stock: 537 shares at $22.72 · code F · owned after 50,358 ·
  • Table I · Common Stock: 942 shares at $22.72 · code F · owned after 52,040 ·
Vosseller LeighEVP & CHIEF FINANCIAL OFFICERExercise or conversion of derivative security (M)Table II · Disposed · Restricted Stock Unit · 2 paired events4,120—Exercise or conversion of derivative security (M)—See lot detailAug 15, 2026
2 filed lots
  • Table II · Restricted Stock Unit: 1,496 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 4,486 · Paired event: 1,496 Restricted Stock Unit → 1,496 Common Stock ·
  • Table II · Restricted Stock Unit: 2,624 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 18,368 · Paired event: 2,624 Restricted Stock Unit → 2,624 Common Stock ·
Sheridan John FDirector, PRESIDENT & CEOExercise or conversion of derivative security (M)Table I · Acquired · Common Stock · 2 paired events15,916—Exercise or conversion of derivative security (M)—See lot detailAug 15, 2026
2 filed lots
  • Table I · Common Stock: 5,982 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 158,425 · Paired event: 5,982 Restricted Stock Unit → 5,982 Common Stock ·
  • Table I · Common Stock: 9,934 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 165,315 · Paired event: 9,934 Restricted Stock Unit → 9,934 Common Stock ·
Sheridan John FDirector, PRESIDENT & CEOPayment of exercise price or tax liability (F)Table I · Disposed · Common Stock8,099$22.72$184,009See lot detailAug 15, 2026
2 filed lots
  • Table I · Common Stock: 3,044 shares at $22.72 · code F · owned after 155,381 ·
  • Table I · Common Stock: 5,055 shares at $22.72 · code F · owned after 160,260 ·
Sheridan John FDirector, PRESIDENT & CEOExercise or conversion of derivative security (M)Table II · Disposed · Restricted Stock Unit · 2 paired events15,916—Exercise or conversion of derivative security (M)—See lot detailAug 15, 2026
2 filed lots
  • Table II · Restricted Stock Unit: 5,982 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 17,947 · Paired event: 5,982 Restricted Stock Unit → 5,982 Common Stock ·
  • Table II · Restricted Stock Unit: 9,934 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 69,537 · Paired event: 9,934 Restricted Stock Unit → 9,934 Common Stock ·
Morrison SusanEVP & Chief Admin. OfficerExercise or conversion of derivative security (M)Table I · Acquired · Common Stock · 2 paired events2,827—Exercise or conversion of derivative security (M)—See lot detailAug 15, 2026
2 filed lots
  • Table I · Common Stock: 1,097 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 51,867 · Paired event: 1,097 Restricted Stock Unit → 1,097 Common Stock ·
  • Table I · Common Stock: 1,730 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 53,283 · Paired event: 1,730 Restricted Stock Unit → 1,730 Common Stock ·
Morrison SusanEVP & Chief Admin. OfficerPayment of exercise price or tax liability (F)Table I · Disposed · Common Stock809$22.72$18,380See lot detailAug 15, 2026
2 filed lots
  • Table I · Common Stock: 314 shares at $22.72 · code F · owned after 51,553 ·
  • Table I · Common Stock: 495 shares at $22.72 · code F · owned after 52,788 ·
Morrison SusanEVP & Chief Admin. OfficerExercise or conversion of derivative security (M)Table II · Disposed · Restricted Stock Unit · 2 paired events2,827—Exercise or conversion of derivative security (M)—See lot detailAug 15, 2026
2 filed lots
  • Table II · Restricted Stock Unit: 1,097 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 3,290 · Paired event: 1,097 Restricted Stock Unit → 1,097 Common Stock ·
  • Table II · Restricted Stock Unit: 1,730 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 12,115 · Paired event: 1,730 Restricted Stock Unit → 1,730 Common Stock ·
Kyrillos Jean-ClaudeEVP & Chief Operating OfficerExercise or conversion of derivative security (M)Table I · Acquired · Common Stock · 1 paired event1,010—Exercise or conversion of derivative security (M)—30,825Aug 15, 2026
1 filed lot
  • Table I · Common Stock: 1,010 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 30,825 · Paired event: 1,010 Restricted Stock Unit → 1,010 Common Stock ·
Kyrillos Jean-ClaudeEVP & Chief Operating OfficerPayment of exercise price or tax liability (F)Table I · Disposed · Common Stock535$22.72$12,15530,290Aug 15, 2026
1 filed lot
  • Table I · Common Stock: 535 shares at $22.72 · code F · owned after 30,290 ·
Kyrillos Jean-ClaudeEVP & Chief Operating OfficerExercise or conversion of derivative security (M)Table II · Disposed · Restricted Stock Unit · 1 paired event1,010—Exercise or conversion of derivative security (M)—7,067Aug 15, 2026
1 filed lot
  • Table II · Restricted Stock Unit: 1,010 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 7,067 · Paired event: 1,010 Restricted Stock Unit → 1,010 Common Stock ·
Gasser Elizabeth AnneEVP, Chief Strategy OfficerExercise or conversion of derivative security (M)Table I · Acquired · Common Stock · 2 paired events3,014—Exercise or conversion of derivative security (M)—See lot detailAug 15, 2026
2 filed lots
  • Table I · Common Stock: 1,097 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 1,097 · Paired event: 1,097 Restricted Stock Unit → 1,097 Common Stock ·
  • Table I · Common Stock: 1,917 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 2,425 · Paired event: 1,917 Restricted Stock Unit → 1,917 Common Stock ·
Gasser Elizabeth AnneEVP, Chief Strategy OfficerPayment of exercise price or tax liability (F)Table I · Disposed · Common Stock1,618$22.72$36,761See lot detailAug 15, 2026
2 filed lots
  • Table I · Common Stock: 589 shares at $22.72 · code F · owned after 508 ·
  • Table I · Common Stock: 1,029 shares at $22.72 · code F · owned after 1,396 ·
Gasser Elizabeth AnneEVP, Chief Strategy OfficerExercise or conversion of derivative security (M)Table II · Disposed · Restricted Stock Unit · 2 paired events3,014—Exercise or conversion of derivative security (M)—See lot detailAug 15, 2026
2 filed lots
  • Table II · Restricted Stock Unit: 1,097 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 3,290 · Paired event: 1,097 Restricted Stock Unit → 1,097 Common Stock ·
  • Table II · Restricted Stock Unit: 1,917 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 13,418 · Paired event: 1,917 Restricted Stock Unit → 1,917 Common Stock ·
Carpenter RickEVP & Chief Technology OfficerExercise or conversion of derivative security (M)Table I · Acquired · Common Stock · 2 paired events2,507—Exercise or conversion of derivative security (M)—See lot detailAug 15, 2026
2 filed lots
  • Table I · Common Stock: 897 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 31,815 · Paired event: 897 Restricted Stock Unit → 897 Common Stock ·
  • Table I · Common Stock: 1,610 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 32,968 · Paired event: 1,610 Restricted Stock Unit → 1,610 Common Stock ·
Carpenter RickEVP & Chief Technology OfficerPayment of exercise price or tax liability (F)Table I · Disposed · Common Stock1,277$22.72$29,013See lot detailAug 15, 2026
2 filed lots
  • Table I · Common Stock: 457 shares at $22.72 · code F · owned after 31,358 ·
  • Table I · Common Stock: 820 shares at $22.72 · code F · owned after 32,148 ·
Carpenter RickEVP & Chief Technology OfficerExercise or conversion of derivative security (M)Table II · Disposed · Restricted Stock Unit · 2 paired events2,507—Exercise or conversion of derivative security (M)—See lot detailAug 15, 2026
2 filed lots
  • Table II · Restricted Stock Unit: 897 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 2,692 · Paired event: 897 Restricted Stock Unit → 897 Common Stock ·
  • Table II · Restricted Stock Unit: 1,610 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 11,268 · Paired event: 1,610 Restricted Stock Unit → 1,610 Common Stock ·
Hansen Shannon MarieEVP & Chief Legal OfficerExercise or conversion of derivative security (M)Table I · Acquired · Common Stock · 2 paired events3,014—Exercise or conversion of derivative security (M)—See lot detailAug 15, 2026
2 filed lots
  • Table I · Common Stock: 1,097 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 31,268 · Paired event: 1,097 Restricted Stock Unit → 1,097 Common Stock ·
  • Table I · Common Stock: 1,917 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 32,626 · Paired event: 1,917 Restricted Stock Unit → 1,917 Common Stock ·
Hansen Shannon MarieEVP & Chief Legal OfficerPayment of exercise price or tax liability (F)Table I · Disposed · Common Stock1,535$22.72$34,875See lot detailAug 15, 2026
2 filed lots
  • Table I · Common Stock: 559 shares at $22.72 · code F · owned after 30,709 ·
  • Table I · Common Stock: 976 shares at $22.72 · code F · owned after 31,650 ·
Hansen Shannon MarieEVP & Chief Legal OfficerExercise or conversion of derivative security (M)Table II · Disposed · Restricted Stock Unit · 2 paired events3,014—Exercise or conversion of derivative security (M)—See lot detailAug 15, 2026
2 filed lots
  • Table II · Restricted Stock Unit: 1,097 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 3,290 · Paired event: 1,097 Restricted Stock Unit → 1,097 Common Stock ·
  • Table II · Restricted Stock Unit: 1,917 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 13,418 · Paired event: 1,917 Restricted Stock Unit → 1,917 Common Stock ·

Source-event as of . Retrieved .

Track record

How Tandem Diabetes Care, Inc.’s moat rated in each of the years we can reconstruct from its filings — scored only on what was knowable at the time — and what its price and returns did afterward. The score never saw a price; the two are joined only in hindsight, for education, not as a signal.

Point-in-time scores 2014–2025, one methodology version · reconstructed from filings on file each Dec 31 — never with hindsight

Point-in-time Moat Score (dot colored by tier)Indexed price (total-return (dividends reinvested))Rated Wide-moat that year

How to read this: each dot is what the engine would have scored TNDM on that December 31; the line below is its total-return price path (dividends reinvested) in the years since.

0406080100WideNarrowShallowNo moatPoint-in-time Moat Score125102050100Indexed price · log scale (2014 = 100)2014201620182020202220242026

Two tracks, one timeline: the score has its own 0–100 scale (top), the price its own 100-based scale (bottom) — never a shared axis. The price path is a total-return (dividends reinvested) index built from the same data the forward returns use; gaps in the score line are years with no reconstructed rating (see the table for why). The Table view carries every value.

What followed, in the years it rated Wide

In the reconstructed history shown, TNDM did not rate Wide-moat in any year, so there is no wide-moat track record to report. That absence is itself the honest answer — we don’t manufacture a comparison where the rating never earned one.

Healthcare context

#391 of 710 scored Healthcare companies, ranked by Moat Score.

Nearest peers by Moat Score

  1. #389LQDA LIQUIDIA CORPORATION38.7No moat
  2. #390MRKR MARKER THERAPEUTICS, INC.38.5No moat
  3. #392NVNO enVVeno Medical Corporation38.5No moat
  4. #393TNGX Tango Therapeutics, Inc.38.5No moat

Compare TNDM with its nearest peers →All Healthcare companies on the Index →

Common questions about TNDM

Does Tandem Diabetes Care, Inc. have an economic moat?
Based on its FY2025 SEC filings, the Moat Index scores Tandem Diabetes Care, Inc. (TNDM) 38.5 out of 100 — below the Shallow-moat bar, so no moat. The five questions behind that score begin at 20% each; if exactly one genuinely lacks data, the other four weights are renormalized and disclosed. revenue and EPS trend 49, pricing power 72, returns on capital 0, balance-sheet safety 28, capital allocation 44.
How has TNDM's Moat Score changed over time?
The record logs 16 readings since Jul 17, 2026; the latest reads 38.5 out of 100 (no moat). No tier changes on record yet. (Methodology or normalizer upgrades on Jul 20, 2026, Jul 23, 2026, Jul 26, 2026 re-based the score; readings across versions aren't compared.) The history is append-only — readings are only ever added, never rewritten.

Scored from primary SEC filings via the public methodology. Educational only — not a recommendation to buy or sell TNDM. See the disclaimer.